S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill reauthorizes the Stem Cell Therapeutic and Research Act of 2005, which supports research and development into stem cell therapies. Specifically, it increases funding for the C.W. Bill Young Cell Transplantation Program, providing additional resources for stem cell transplantation. The bill also updates a provision regarding cord blood inventory to align with the extended funding period. It aims to bolster the advancement of stem cell science and its potential applications in treating diseases.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 2d Session
S. 4109
IN THE SENATE OF THE UNITED STATES
A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2026
.
Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended—
by striking appropriated $31,009,000
and inserting the following:
appropriated—
in paragraph (1), as so inserted, by striking the period at the end and inserting ; and
; and
by adding at the end the following:
Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking 2026
and inserting 2031
.